← back to search

Andrew Jones

Deleted Institution · GB
Area of research
Radiology, Nuclear Medicine and Imaging · Molecular Biology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Chronic Lymphocytic Leukemia Research, and Respiratory Support and Mechanisms.
h-index
24
citations
2,130
works
100
NIH funding
primary concept
Medicine
email

Recent publications

Practice Readiness of Chief Residents in a National Sample During the First Year of EPA Assessments
Annals of Surgery 2025cited by 4position: middledoi
Ventilator Weaning and Discontinuation Practices for Critically Ill Patients
JAMA 2021cited by 207position: middledoi
HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
Nature Communications 2019cited by 75position: firstdoi
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques
Journal of Virology 2017cited by 37position: firstdoi
Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies
Critical Care 2016cited by 130position: middledoi
Pharmacist’s review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK)
Journal of Critical Care 2015cited by 63position: middledoi
Oral Immunization with a Recombinant <i>Lactococcus lactis</i>–Expressing HIV-1 Antigen on Group A <i>Streptococcus</i> Pilus Induces Strong Mucosal Immunity in the Gut
The Journal of Immunology 2015cited by 51position: middledoi
Association of the 2011 ACGME Resident Duty Hour Reform With General Surgery Patient Outcomes and With Resident Examination Performance
JAMA 2014cited by 138position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rama Rao Amara · Emory Healthcare3 papers (2015–2019)Xiaoying Shen · Ministry of Education of the People's Republic of China2 papers (2017–2019)Celia C. LaBranche · Duke Medical Center2 papers (2017–2019)Raghavan Varadarajan · National University of Singapore2 papers (2017–2019)David C. Montefiori · Duke University2 papers (2017–2019)Venkateswarlu Chamcha · Merck & Co., Inc., Rahway, NJ, USA (United States)2 papers (2015–2017)Linda S. Wyatt · National Institute of Allergy and Infectious Diseases2 papers (2017–2019)Georgia D. Tomaras · International Vaccine Institute2 papers (2017–2019)Bernard Moss · National Institute of Allergy and Infectious Diseases2 papers (2017–2019)Kallirroi Kefala · Clinical Trial Investigators1 papers (2021–2021)Brenessa Lindeman · University of Alabama at Birmingham1 papers (2025–2025)Guido Ferrari · Duke University1 papers (2017–2017) · 1 papers (2017–2017)Mark E. Cohen · American College of Surgeons1 papers (2014–2014)Leena Rizvi · St. Michael's Hospital1 papers (2021–2021)Michael Ambler · St Thomas' Hospital1 papers (2016–2016) · 1 papers (2025–2025)Dan H. Barouch · Harvard University1 papers (2019–2019)Peter Dodek · University of British Columbia1 papers (2021–2021)Ruchi Thanawala · University of Massachusetts Chan Medical School1 papers (2025–2025)